menu search

Tenaya Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update

Tenaya Therapeutics Reports First Quarter 2023 Financial Results and  Provides Business Update
TN-201 Received Fast Track Designation from the FDA Dosing Complete in Phase 1 Clinical Trial of TN-301; Data Expected in Second Half 2023 Renowned Researchers Drs. Christine Seidman and Alex Marson Join Scientific Advisory Board Announces Formation of Technical Advisory Board with Deep Expertise in Gene Therapy Manufacturing SOUTH SAN FRANCISCO, Calif., May 10, 2023 […] The post Tenaya Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update appeared first on Fore... Read More
Posted: May 10 2023, 20:19
Author Name: forextv
Views: 102048

Search within

Pages Search Results: